GO:0036198 dTMP salvage: Nucleotide Recycling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036198 dTMP salvage is the biological process that produces deoxythymidine monophosphate (dTMP) from preformed nucleosides or nucleobases, bypassing thymidylate synthase-dependent de novo synthesis.
• Salvage of thymidine and deoxyuridine is essential for mitochondrial DNA maintenance and for balancing dTTP pools in proliferating cells.
• Key enzymes include thymidine kinase 1 (TK1), thymidine kinase 2 (TK2), thymidylate kinase (DTYMK), and nucleoside diphosphate kinase (NME1/2), which sequentially phosphorylate thymidine to dTMP and beyond.
• DNPH1 (RCL) removes 5-hydroxymethyl-dUMP from DNA, and its loss creates a dependency on dTMP salvage, linking the pathway to BRCA-deficient cancer therapy.
• Dysregulated dTMP salvage contributes to chemotherapy resistance and is a target for antifolate and nucleoside analog drugs.
• CRISPR knockout, point mutation, and knock-in models of TK1, TK2, DTYMK, and DNPH1 enable precise dissection of dTMP salvage in cancer, mitochondrial disease, and drug response.
Description
dTMP salvage (GO:0036198) is a fundamental nucleotide recycling process that generates deoxythymidine monophosphate (dTMP) without relying on de novo thymidylate synthesis. In proliferating cells, dTMP is a rate-limiting precursor for dTTP and DNA replication; salvage allows cells to reuse thymidine derived from extracellular sources or from DNA degradation, thereby conserving energy and one-carbon units. This pathway is particularly important in tissues with high nucleotide turnover, such as bone marrow, intestinal epithelium, and tumors. The salvage route also operates in mitochondria, where it supports mitochondrial DNA (mtDNA) maintenance independently of cytosolic de novo synthesis. Because dTMP salvage intersects with chemotherapy, mitochondrial disease, and DNA repair, it has become a focal point for CRISPR-based functional genomics. Understanding the genes and regulatory logic of dTMP salvage is therefore essential for researchers in cancer biology, metabolism, and genome stability.
dTMP salvage At A Glance
| GO ID | GO:0036198 |
|---|---|
| GO term | dTMP salvage |
| Ontology | biological_process |
| Synonym | deoxythymidine monophosphate biosynthesis via salvage pathway; dTMP biosynthesis via salvage pathway |
| Major function | Production of dTMP from preformed thymidine or deoxyuridine, bypassing de novo synthesis |
| Key enzymes | TK1, TK2, DTYMK, NME1/2, DNPH1 |
| Subcellular locations | Cytosol, mitochondria, nucleus |
| Related pathways | Pyrimidine salvage, mitochondrial nucleotide metabolism, DNA repair |
| Disease relevance | Cancer chemotherapy resistance, mitochondrial DNA depletion syndromes, BRCA-deficient tumors |
What Is GO:0036198?
According to the Gene Ontology, dTMP salvage (GO:0036198) is defined as any process which produces dTMP, deoxyribosylthymine monophosphate (2'-deoxyribosylthymine 5'-phosphate), without de novo synthesis. In practice, this means cells can generate dTMP by phosphorylating preformed thymidine (via thymidine kinase) or by converting deoxyuridine monophosphate (dUMP) through alternative routes that do not involve thymidylate synthase. The term encompasses both cytosolic and mitochondrial salvage activities and is distinct from de novo dTMP biosynthesis, which requires folate-dependent methylation of dUMP.
Why Is dTMP salvage Important in Cell Biology?
dTMP salvage is critical for maintaining dTTP pools required for DNA replication and repair, especially when de novo synthesis is compromised by antifolate drugs or metabolic stress. In mitochondria, salvage enzymes such as TK2 and CMPK2 are essential for mtDNA maintenance, and their dysfunction causes severe mitochondrial DNA depletion syndromes. In cancer, upregulation of salvage enzymes can confer resistance to thymidylate synthase inhibitors, while loss of DNPH1 creates a synthetic lethal dependency on dTMP salvage in BRCA-deficient cells, offering a therapeutic window. Thus, dTMP salvage is both a basic metabolic pathway and a clinically actionable vulnerability.
• Provides dTMP for DNA replication when de novo synthesis is inhibited by antifolates or 5-fluorouracil.
• Supports mitochondrial DNA synthesis and repair through mitochondrial salvage enzymes TK2 and CMPK2.
• Enables recycling of thymidine from extracellular sources or DNA degradation, conserving one-carbon units.
• Loss of DNPH1 (RCL) causes accumulation of 5-hydroxymethyl-dUMP and sensitizes BRCA-deficient cells to PARP inhibitors.
• Dysregulation of thymidine kinase 1 (TK1) is a biomarker for cell proliferation in cancer.
• Mutations in TK2 cause mitochondrial DNA depletion syndrome with myopathy and encephalopathy.
• Salvage pathway activity modulates sensitivity to nucleoside analog drugs used in cancer and antiviral therapy.
• Plant mitochondria also salvage deoxyribonucleosides, indicating evolutionary conservation.
• dTMP salvage intersects with folate metabolism and nuclear folate enzymes.
• CRISPR screens targeting salvage genes can identify new therapeutic targets in chemotherapy-resistant tumors.
What Happens During dTMP salvage?
Thymidine uptake and phosphorylation by TK1
In simple terms: Cells take up thymidine from outside and add a phosphate group to make dTMP.
In the cytosol, thymidine kinase 1 (TK1) catalyzes the ATP-dependent phosphorylation of thymidine to dTMP. TK1 is cell-cycle regulated, peaking in S phase, and is a classic marker of proliferation. This step is the first committed step of the salvage pathway and directly produces dTMP, fulfilling the GO:0036198 definition.
Mitochondrial thymidine phosphorylation by TK2
In simple terms: Inside mitochondria, a different enzyme TK2 makes dTMP from thymidine to support mitochondrial DNA.
Thymidine kinase 2 (TK2) phosphorylates thymidine and deoxycytidine in mitochondria, and its activity is essential for mtDNA maintenance. Compartmentalized thymidine phosphorylation by TK2 and CMPK2 ensures a local supply of dTMP for mitochondrial DNA synthesis. Loss of TK2 causes mitochondrial DNA depletion syndromes, highlighting the importance of this salvage route.
Phosphorylation of dTMP to dTDP and dTTP
In simple terms: dTMP is further phosphorylated to dTDP and then dTTP, the building block for DNA.
Thymidylate kinase (DTYMK) phosphorylates dTMP to dTDP, and nucleoside diphosphate kinase (NME1/2) converts dTDP to dTTP. These sequential phosphorylations link dTMP salvage to the broader pyrimidine nucleotide pool. The pathway ensures that salvaged dTMP is efficiently incorporated into DNA.
Salvage of deoxyuridine and dUMP
In simple terms: Cells can also salvage deoxyuridine and convert it to dTMP through alternative routes.
Deoxyuridine can be phosphorylated by TK2 or other nucleoside kinases to dUMP, which can then be methylated to dTMP by thymidylate synthase or converted via other salvage enzymes. DNPH1 (RCL) hydrolyzes 5-hydroxymethyl-dUMP to 5-hydroxymethyl-deoxyuridine, preventing its incorporation into DNA and influencing dTMP salvage dependency. This step is critical for genome stability and is targeted in BRCA-deficient cancers.
Compartmentalization and regulation
In simple terms: The salvage pathway operates in both cytosol and mitochondria, with different enzymes and regulation.
Cytosolic salvage is primarily mediated by TK1 and DTYMK, while mitochondrial salvage relies on TK2 and CMPK2. The two compartments are regulated independently, and mitochondrial salvage is essential when cytosolic de novo synthesis is insufficient. This compartmentalization allows cells to maintain dTTP pools for nuclear and mitochondrial DNA replication under varying metabolic conditions.
Key Genes Involved in GO:0036198 dTMP salvage
The following genes encode enzymes and regulators directly involved in dTMP salvage (GO:0036198) and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TK1 | Cytosolic thymidine kinase; phosphorylates thymidine to dTMP | Cell proliferation marker; target in cancer therapy |
| TK2 | Mitochondrial thymidine kinase; phosphorylates thymidine and deoxycytidine | Mutations cause mtDNA depletion syndromes |
| DTYMK | Thymidylate kinase; phosphorylates dTMP to dTDP | Essential for dTTP synthesis; potential drug target |
| NME1 | Nucleoside diphosphate kinase; converts dTDP to dTTP | Metastasis suppressor; involved in nucleotide metabolism |
| NME2 | Nucleoside diphosphate kinase; converts dTDP to dTTP | Regulates dTTP pools; implicated in cancer |
| DNPH1 | Hydrolyzes 5-hydroxymethyl-dUMP; affects dTMP salvage dependency | Synthetic lethal with BRCA deficiency |
| CMPK2 | Mitochondrial cytidine/uridine monophosphate kinase; supports dTMP salvage | Compartmentalized thymidine phosphorylation |
| TYMS | Thymidylate synthase; de novo dTMP synthesis | Target of 5-fluorouracil; opposes salvage |
| MTHFR | Methylenetetrahydrofolate reductase; folate metabolism | Links folate cycle to dTMP synthesis |
| SHMT1 | Serine hydroxymethyltransferase; one-carbon metabolism | Nuclear folate metabolism; affects dTMP synthesis |
| MTHFD1 | Methylenetetrahydrofolate dehydrogenase; folate metabolism | Provides one-carbon units for de novo dTMP |
| SLC29A1 | Equilibrative nucleoside transporter; thymidine uptake | Influences salvage substrate availability |
| SLC29A2 | Equilibrative nucleoside transporter; thymidine uptake | Modulates intracellular thymidine levels |
| DCK | Deoxycytidine kinase; phosphorylates deoxycytidine and deoxyuridine | Can contribute to dUMP salvage |
| NT5C | Cytosolic 5'-nucleotidase; dephosphorylates nucleotides | Regulates nucleotide pools |
| RRM1 | Ribonucleotide reductase; produces deoxyribonucleotides | Supports dTMP synthesis indirectly |
| RRM2 | Ribonucleotide reductase; produces deoxyribonucleotides | Cell cycle regulated; target in cancer |
How Is dTMP salvage Regulated?
dTMP salvage is regulated at multiple levels. TK1 expression is cell-cycle dependent, peaking during S phase to meet increased demand for dTTP. Mitochondrial TK2 is constitutively expressed but its activity is modulated by substrate availability and post-translational modifications. DNPH1 levels influence the dependency on dTMP salvage, and its loss activates compensatory pathways. Folate metabolism and one-carbon availability also impact the balance between de novo synthesis and salvage, as nuclear folate enzymes such as SHMT1 and MTHFD1 supply methyl groups for de novo dTMP. Additionally, chemotherapy agents that inhibit de novo synthesis can upregulate salvage enzymes, leading to drug resistance.
dTMP salvage and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TK2 | Mitochondrial DNA depletion syndrome | TK2 knockout or point-mutation knock-in in cell lines |
| DNPH1 | BRCA-deficient cancer sensitivity to PARP inhibitors | DNPH1 knockout in BRCA-mutant cancer cells |
| TK1 | Cancer proliferation and chemotherapy resistance | TK1 overexpression or knockout in cancer cell lines |
| DTYMK | Chemotherapy resistance and nucleotide imbalance | DTYMK knockout or point mutation |
| CMPK2 | Mitochondrial nucleotide imbalance | CMPK2 knockout in mitochondrial disease models |
Cancer and Chemotherapy Resistance
Upregulation of dTMP salvage enzymes, particularly TK1, is observed in many cancers and correlates with poor prognosis. Thymidylate synthase inhibitors such as 5-fluorouracil block de novo dTMP synthesis, but cancer cells can escape by increasing salvage activity. Targeting salvage enzymes, such as DTYMK or TK1, may overcome resistance. In BRCA-deficient tumors, loss of DNPH1 creates a dependency on dTMP salvage, and PARP inhibitors exploit this synthetic lethal interaction.
Mitochondrial DNA Depletion Syndromes
Mutations in TK2 cause severe mitochondrial DNA depletion syndromes characterized by myopathy and encephalopathy. TK2 deficiency impairs mitochondrial dTMP salvage, leading to mtDNA depletion and respiratory chain dysfunction. Similarly, defects in CMPK2 affect mitochondrial nucleotide pools and can contribute to mitochondrial disease. These disorders highlight the essential role of dTMP salvage in mitochondrial genome maintenance.
Genome Instability and DNA Repair
DNPH1 (RCL) removes 5-hydroxymethyl-dUMP from DNA, and its loss leads to accumulation of this modified nucleotide, causing DNA damage and sensitivity to PARP inhibitors. This links dTMP salvage to base excision repair and genome stability. Deoxyuracil in DNA, a consequence of imbalanced dTMP salvage, is associated with mutagenesis and disease.
From dTMP salvage-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TK1 affect dTMP salvage and cell proliferation? | TK1 knockout cell line |
| Does a specific TK2 mutation cause mtDNA depletion? | TK2 point-mutation knock-in |
| Can DNPH1 loss sensitize BRCA-deficient cells to PARP inhibitors? | DNPH1 knockout in BRCA-mutant background |
| Does overexpression of DTYMK increase dTTP pools and drug resistance? | DTYMK overexpression cell line |
| Where is TK2 localized within mitochondria? | TK2 tagged knock-in with fluorescent tag |
| Does CMPK2 interact with TK2 in mitochondrial salvage? | CMPK2 knockout and co-immunoprecipitation |
How to Study the dTMP salvage Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | dTMP, dTDP, dTTP levels | Quantify salvage flux after gene knockout |
| CRISPR knockout screen | Gene essentiality and synthetic lethality | Identify dTMP salvage dependencies |
| qPCR for mtDNA | Mitochondrial DNA copy number | Assess TK2 or CMPK2 dysfunction |
| Fluorescence microscopy | Subcellular localization of tagged enzymes | Study compartmentalized salvage |
| Western blot | Protein expression levels | Validate knockout or overexpression |
| Cell proliferation assay | Growth rate and viability | Measure impact of salvage gene loss |
| Drug sensitivity assay | IC50 for antifolates or PARP inhibitors | Test synthetic lethality |
| RNA-seq | Transcriptional changes | Identify compensatory pathways |
CRISPR Knockout Screens
Genome-wide CRISPR knockout screens can identify genes required for dTMP salvage under specific conditions, such as folate deprivation or thymidylate synthase inhibition. These screens reveal synthetic lethal interactions and compensatory pathways.
Metabolomics and Nucleotide Pool Analysis
Liquid chromatography-mass spectrometry (LC-MS) can quantify dTMP, dTDP, and dTTP levels in cells with genetic perturbations. This method directly measures the impact of gene knockouts or point mutations on dTMP salvage flux.
Mitochondrial DNA Copy Number and Integrity Assays
Quantitative PCR and Southern blotting measure mtDNA copy number and deletions in cells with TK2 or CMPK2 mutations. These assays are essential for studying mitochondrial dTMP salvage defects.
Fluorescence Imaging of Tagged Salvage Enzymes
Knock-in of fluorescent tags (e.g., GFP) into endogenous TK2 or TK1 loci allows live-cell imaging of enzyme localization and dynamics. This approach reveals compartment-specific salvage activity.
How CRISPR Can Be Used to Study GO:0036198 dTMP salvage
Knockout
CRISPR knockout of TK1, TK2, DTYMK, or DNPH1 creates cell models to study dTMP salvage loss. For example, DNPH1 knockout in BRCA-deficient cells increases sensitivity to PARP inhibitors, validating synthetic lethality. TK2 knockout recapitulates mitochondrial DNA depletion phenotypes.
Point Mutation
Point mutations in TK2 or DTYMK can mimic patient-derived mutations, allowing structure-function analysis of salvage enzymes. CRISPR-mediated point mutation knock-in enables precise modeling of disease-associated variants.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous TK1, TK2, or CMPK2 loci allows visualization and immunoprecipitation of salvage complexes. This approach preserves endogenous regulation and localization.
Overexpression
CRISPR activation or cDNA overexpression of TK1 or DTYMK can model chemotherapy resistance and increased dTTP pools. Overexpression studies help identify rate-limiting steps in dTMP salvage.
How EDITGENE Supports dTMP salvage Research
Researchers studying dTMP salvage-related genes often need to determine whether a candidate gene is causally involved in dTMP production, mitochondrial DNA maintenance, or drug resistance. EDITGENE provides custom CRISPR cell models to test these hypotheses with precision.
Contact EDITGENE today to design your custom CRISPR model for dTMP salvage research.
Frequently Asked Questions About dTMP salvage
What is dTMP salvage (GO:0036198)?
dTMP salvage is the biological process that produces deoxythymidine monophosphate (dTMP) from preformed thymidine or deoxyuridine, without de novo synthesis.
What genes are involved in dTMP salvage?
Key genes include TK1, TK2, DTYMK, NME1/2, DNPH1, and CMPK2, which phosphorylate or modify thymidine and its derivatives.
Why is dTMP salvage important for mitochondria?
Mitochondria rely on TK2 and CMPK2 for dTMP salvage to maintain mitochondrial DNA, and defects cause mtDNA depletion syndromes.
How is dTMP salvage related to cancer?
Upregulation of salvage enzymes like TK1 can cause resistance to antifolate drugs, while DNPH1 loss sensitizes BRCA-deficient tumors to PARP inhibitors.
What is the difference between de novo and salvage dTMP synthesis?
De novo synthesis uses thymidylate synthase to methylate dUMP, while salvage uses preformed thymidine and kinases like TK1/TK2.
Can CRISPR be used to study dTMP salvage?
Yes, CRISPR knockout, point mutation, and knock-in models of TK1, TK2, DTYMK, and DNPH1 are widely used to dissect the pathway.
What diseases are linked to dTMP salvage defects?
Mitochondrial DNA depletion syndrome (TK2 mutations), cancer drug resistance, and genome instability (DNPH1 loss) are linked to dTMP salvage.
How do you measure dTMP salvage activity?
LC-MS metabolomics can quantify dTMP and dTTP pools, and mitochondrial DNA copy number assays assess salvage function.
Is dTMP salvage conserved in plants?
Yes, plants salvage deoxyribonucleosides in mitochondria, indicating evolutionary conservation.
What are the synonyms for GO:0036198?
Synonyms include deoxythymidine monophosphate biosynthesis via salvage pathway and dTMP biosynthesis via salvage pathway.
Conclusion
dTMP salvage (GO:0036198) is a vital metabolic pathway that ensures a steady supply of dTMP for DNA replication and repair, particularly in mitochondria and proliferating cells. Its dysregulation is implicated in cancer chemotherapy resistance, mitochondrial DNA depletion syndromes, and genome instability. CRISPR-based models of TK1, TK2, DTYMK, and DNPH1 provide powerful tools to dissect the molecular mechanisms and identify therapeutic targets. Continued research into dTMP salvage will likely yield new strategies for treating cancers and mitochondrial disorders.
References
- 2. Fugger K et al.. 2021. Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors.. Science 372(6538):156-165 PMID: 33833118
- 3. Field MS et al.. 2018. Nuclear Folate Metabolism.. Annu Rev Nutr 38:219-243 PMID: 30130467
- 5. Clausen AR et al.. 2014. Plants salvage deoxyribonucleosides in mitochondria.. Nucleosides Nucleotides Nucleic Acids 33(4-6):291-5 PMID: 24940682
- 6. Ward AS et al.. 2025. Compartmentalized thymidine phosphorylation by mitochondrial nucleotide kinases TK2 and CMPK2.. J Biol Chem 301(11):110733 PMID: 40967432
- 7. Chon J et al.. 2019. Deoxyuracil in DNA and disease: Genomic signal or managed situation?. DNA Repair (Amst) 77:36-44 PMID: 30875637
- 8. Weber G et al.. 1991. Regulation of de novo and salvage pathways in chemotherapy.. Adv Enzyme Regul 31:45-67 PMID: 1877399
